France's Novagali Pharma has raised €26 million in a new round of venture capital. Novagali has raised €44 million since its inception. AGF Private Equity and Bernard Chauvin joined the group of Novagali Pharma's investors: 1.2.3. Multinova, Auriga Partners, CDC Enterprises Innovation, Credit Agricole Private Equity, Edmond de Rothschild Investment Partners, FCJE managed by CDC Entreprises-FP Gestion and Siparex Ventures.
- here's the release for more
PLUS: SkinMedica has raised $11.2 million in its fifth round. Release